By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Molecular diagnostics startup Xagenic today announced the closing of a Series A financing round that raised C$10 million (US$10 million).

CTI Life Sciences Fund and the Ontario Emerging Technologies Fund led the round, with "significant participation" by Qiagen, Toronto-based Xagenic said. The money will go toward the development of a decentralized molecular diagnostic platform for use in doctors' offices, clinics, and hospital systems.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.